EC
TTPH

EcoR1 Capital’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

EcoR1 Capital’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-31,670
Closed -$4.52M – 49
2017
Q2 		$4.52M Buy
+31,670
New +$4.89M 0.8% 21

Other funds holding TTPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EcoR1 Capital's TTPH Position: Q3 2017 in Review

EcoR1 Capital sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2017, closing a stake of 31,670 shares — an estimated $4.52M sold.

EcoR1 Capital first reported a position in TTPH in Q2 2017 and held it in 1 quarter. The position peaked at $4.52M in Q2 2017. 94 funds tracked by Wall St. Rank hold TTPH as of Q3 2017.

  • EcoR1 Capital reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • EcoR1 Capital sold 31,670 Tetraphase Pharmaceuticals, Inc. shares in Q3 2017, an estimated $4.52M.
  • EcoR1 Capital first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2017 and held it in 1 quarter.
  • EcoR1 Capital's Tetraphase Pharmaceuticals, Inc. position peaked at $4.52M in Q2 2017.
  • 94 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2017.

Based on EcoR1 Capital's 13F filing for Q3 2017, filed 14 Nov 2017.